FDA Approves New Injection for Diabetic Retinopathy

Regeneron Pharmaceuticals, Inc. announced yesterday that the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to …

Special Spotlight On Diabetes Insulins: Soliqua 100/33 (insulin glargine/lixisenatide)

Medically reviewed by Lindsay Slowiczek, PharmD on April 5, 2019. Written by Victor Nguyen, PharmD, MS. Republished with permission from Healthline. …

Special Spotlight On Diabetes Insulins: Ozempic (semaglutide)

Medically reviewed by Lindsay Slowiczek, PharmD. 1/19. Republished with permission from Healthline. In a special partnership, dLife is proud to …

Special Spotlight on Diabetes Insulins: Bydureon (exenatide)

Medically reviewed by Lindsay Slowiczek, PharmD. 11/18. Republished with permission from Healthline. In a special partnership, dLife is proud to …

Special Spotlight on Diabetes Insulins: Farxiga (dapagliflozin)

Medically reviewed by Lindsay Slowiczek, PharmD. 11/18. Republished with permission from Healthline. In a special partnership, dLife is proud to …

Mount Sinai Researchers: Diabetes Drug May Reverse Heart Failure

Researchers have demonstrated that the recently developed antidiabetic drug empagliflozin can treat and reverse the progression of heart failure in …

Special Spotlight on Diabetes Insulins: Toujeo (insulin glargine)

Medically reviewed by Lindsay Slowiczek, PharmD. 11/18. Republished with permission from Healthline. In a special partnership, dLife is proud to …

Cigna; Express Scripts Announce Program to Cap Insulin Cost to $25/Month

Cigna and Express Scripts announced today the launch of a new program which will ensure eligible people with diabetes in participating plans pay no …

Janssen Submits sNDA for INVOKANA® for Chronic Kidney Disease in Patients with Type 2 Diabetes

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a supplemental New Drug Application (sNDA) to the …

Oramed Gets Patent for Key Aspect of Its Oral Delivery Technology in U.S.

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that it has …